Research Topics
| D AletahaSummaryAffiliation: Medical University of Vienna Country: Austria Publications
| Collaborators
|
Detail Information
Publications
Rituximab dissociates the tight link between disease activity and joint damage in rheumatoid arthritis patientsDaniel Aletaha
Department of Medicine 3, Medical University of Vienna, Vienna, Austria
Ann Rheum Dis 72:7-12. 2013..It is hitherto unknown if this may also be true for therapies targeting B-cells. We thus evaluated if rituximab (RTX) therapy inhibits joint damage irrespective of its effects on disease activity...
Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritisChristoph Böhler
Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Waehringer Guertel 18 20, Vienna 1090, Austria
Ann Rheum Dis 72:241-4. 2013..To investigate changes of rheumatoid factor (RF) and antibodies against citrullinated peptides (ACPA) during therapy with disease modifying antirheumatic drugs...
Near misses of ACR/EULAR criteria for remission: effects of patient global assessment in Boolean and index-based definitionsPaul Studenic
Division of Rheumatology, Department of Internal Medicine 3, Medical University Vienna, 1090 Vienna, Austria
Ann Rheum Dis 71:1702-5. 2012..The American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis (RA) have been published recently...
Nothing lasts forever - a critical look at sustained remissionDaniel Aletaha
Division of Rheumatology, Medical University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
Arthritis Res Ther 14:116. 2012..A study by Prince and colleagues gives insights into this question, and raises some other questions for the future...
Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity indexDaniel Aletaha
Medical University of Vienna, Department of Rheumatology, Spitalgasse 23, 1090 Vienna, Austria
Ann Rheum Dis 71:1190-6. 2012..To date, no validated response definitions for the SDAI and CDAI are available...
Disease activity level, remission and response in established rheumatoid arthritis: performance of various criteria sets in an observational cohort, treated with anti-TNF agentsAnders Gülfe
Dept of Rheumatology, Lund University Hospital, Lund, Sweden
BMC Musculoskelet Disord 10:41. 2009..We therefore wanted to compare the performance of the DAS28, SDAI and CDAI activity indices, their activity states, their response criteria, and also compare with the ACR response criteria in an observational clinical setting...
Remission by composite scores in rheumatoid arthritis: are ankles and feet important?Theresa Kapral
Department of Rheumatology, Medical University of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
Arthritis Res Ther 9:R72. 2007..However, reduced joint counts are appropriate and valid tools for formal disease activity assessment, such as done in composite indices...
Developments in the clinical understanding of rheumatoid arthritisJosef S Smolen
Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, and 2nd Department of Medicine, Hietzing Hospital, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Arthritis Res Ther 11:204. 2009..Finally, with the advent of novel therapies, remission has become a reality and the treatment algorithms encompassing all of the above-mentioned aspects will allow us to achieve the rigorous aspirations of today and tomorrow...
Rheumatoid arthritis near remission: clinical rather than laboratory inflammation is associated with radiographic progressionDaniel Aletaha
Department of Medicine 3, Division of Rheumatology, Medical University Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Ann Rheum Dis 70:1975-80. 2011..In general, both contribute to the progression of joint damage, but the relevance of residual inflammation in patients near remission is unclear...
The definition and measurement of disease modification in inflammatory rheumatic diseasesDaniel Aletaha
Department of Rheumatology, Internal Medicine III, Medical University of Vienna, Vienna, Austria
Rheum Dis Clin North Am 32:9-44, vii. 2006....
Perception of improvement in patients with rheumatoid arthritis varies with disease activity levels at baselineD Aletaha
Department of Internal Medicine 3, Medical University of Vienna, Vienna, Austria
Arthritis Rheum 61:313-20. 2009..To analyze the minimum clinically important improvement (MCII) of disease activity measures in rheumatoid arthritis (RA) using patient-derived anchors, and to assess whether criteria for improvement differ with baseline disease activity...
The perception of rheumatoid arthritis core set measures by rheumatologists. Results of a surveyD Aletaha
Department of Rheumatology, Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Rheumatology (Oxford) 45:1133-9. 2006..To investigate the perception of values of individual core set measures by rheumatologists, and how it differs across measures and across physicians...
The use of data from early arthritis clinics for clinical researchDaniel Aletaha
Division of Rheumatology, Department of Internal Medicine 3, Medical University of Vienna, Vienna, Austria
Best Pract Res Clin Rheumatol 23:117-23. 2009....
[Rheumatoid arthritis. Target outcome for treatment]D Aletaha
Klinische Abteilung für Rheumatologie, Klinik für Innere Medizin 3, Medizinische Universität Wien, Wahringer Gurtel 18 20, 1090, Wien, Osterreich
Z Rheumatol 68:10-5. 2009..Standardised intensive therapeutic strategies and algorithms should form the basis for the administration of anti-rheumatic medication...
Measuring function in rheumatoid arthritis: Identifying reversible and irreversible componentsDaniel Aletaha
National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland, USA
Arthritis Rheum 54:2784-92. 2006..We aimed to dissect these two components of functional limitation in rheumatoid arthritis (RA) by using the disability index of the Health Assessment Questionnaire (HAQ) as the measure of function...
Remission of rheumatoid arthritis: should we care about definitions?D Aletaha
Department of Rheumatology, Medical University of Vienna, Vienna, Austria
Clin Exp Rheumatol 24:S-45-51. 2006..All composite indices seem to perform similarly well as tests for remission using expert judgments as the gold standard...
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendationsD Aletaha
Division of Rheumatology, Medical University of Vienna, Vienna, Austria
Ann Rheum Dis 67:1360-4. 2008..To make recommendations on how to report disease activity in clinical trials of rheumatoid arthritis (RA) endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR)...
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendationsD Aletaha
Medical University of Vienna, Vienna, Austria
Arthritis Rheum 59:1371-7. 2008..To make recommendations on how to report disease activity in clinical trials of rheumatoid arthritis (RA) endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR)...
Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritisT Karonitsch
Division of Rheumatology, Medical University of Vienna, Vienna, Austria
Ann Rheum Dis 67:1365-73. 2008....
The health assessment questionnaire in routine clinical practiceDaniel Aletaha
Division of Rheumatology, Medical University of Vienna, Vienna, Austria
Nat Clin Pract Rheumatol 3:122-3. 2007
Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: a pooled analysis of clinical trial resultsD Aletaha
Department of Rheumatology, Internal Medicine III, Medical University of Vienna, Austria
Ann Rheum Dis 67:238-43. 2008....
[Measuring disease activity for rheumatoid arthritis]D Aletaha
Klinische Abt für Rheumatologie, Universitätsklinik für Innere Medizin III, Wien
Z Rheumatol 65:93-6, 98-102. 2006..This will further improve our ability to care for patients with RA consequently...
Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessmentD Aletaha
Division of Rheumatology, Medical University of Vienna, Vienna, Austria
Arthritis Rheum 60:1242-9. 2009..The aim of this study was to evaluate whether there is a latency in the effect of disease activity on radiographic progression in patients with RA...
The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritisD Aletaha
Department of Rheumatology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Clin Exp Rheumatol 23:S100-8. 2005....
Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen jointsDaniel Aletaha
Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
Arthritis Rheum 63:3702-11. 2011..This study was undertaken to investigate the significance of residual inflammation in remission in relation to radiographic progression...
Treating rheumatic patients with a malignancyKatarzyna Elandt
Division of Oncology, Department of Internal Medicine 1, Medical University Vienna, Austria
Arthritis Res Ther 13:223. 2011..In conclusion, the decision to treat a patient with a history of cancer immunosuppressively should be shared by the rheumatologist and the oncologist. Once the decision is established, such patients need intensive and close monitoring...
The importance of reporting disease activity states in rheumatoid arthritis clinical trialsDaniel Aletaha
Medical University of Vienna, Vienna, Austria
Arthritis Rheum 58:2622-31. 2008..g., American College of Rheumatology [ACR] responder status) with the value of evaluating absolute disease activity states (e.g., remission)...
Physical disability in rheumatoid arthritis is associated with cartilage damage rather than bone destructionDaniel Aletaha
Department of Internal Medicine 3, Division of Rheumatology, Medical University Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
Ann Rheum Dis 70:733-9. 2011..It is currently unclear to which extent these components affect irreversible functional disability. The aim of the present work was to determine these contributions...
Remission and active disease in rheumatoid arthritis: defining criteria for disease activity statesDaniel Aletaha
Department of Rheumatology, Medical University of Vienna, Vienna, Austria
Arthritis Rheum 52:2625-36. 2005..We aimed to reevaluate or to define such criteria for the Disease Activity Score in 28 joints (DAS28) and the Simplified Disease Activity Index (SDAI)...
Attitudes to early rheumatoid arthritis: changing patterns. Results of a surveyD Aletaha
Division of Rheumatology, Department of Internal Medicine III, University of Vienna, Vienna General Hospital, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Ann Rheum Dis 63:1269-75. 2004..To determine if rheumatologists have changed their views on diagnosis and treatment of early rheumatoid arthritis (RA)...
The Simplified Disease Activity Index and Clinical Disease Activity Index to monitor patients in standard clinical careDaniel Aletaha
Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Rheum Dis Clin North Am 35:759-72, viii. 2009..Moreover, remission criteria of CDAI and SDAI are currently the most stringent...
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockadeJ S Smolen
Department of Internal Medicine III, Medical University of Vienna, Austria
Ann Rheum Dis 68:823-7. 2009..To examine the association of radiographic progression and disease activity states in patients with rheumatoid arthritis (RA) treated with methotrexate with or without infliximab...
Step-up combination versus switching of non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a retrospective observational studyM Schoels
Second Department of Medicine, Hietzing Hospital, Vienna, Austria
Ann Rheum Dis 66:1059-65. 2007..In rheumatoid arthritis (RA), treatment with disease-modifying antirheumatic drugs (DMARDs) frequently needs to be changed because of insufficient effectiveness...
Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational studyD Aletaha
Division of Rheumatology, Department of Internal Medicine III, University of Vienna, Austria
Ann Rheum Dis 62:944-51. 2003..To determine the survival and clinical effectiveness of leflunomide (LEF) compared with methotrexate (MTX) and sulfasalazine (SSZ) for RA in an observational study...
Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of diseaseK P Machold
Department of Rheumatology, Medical University of Vienna, Vienna, Austria
Rheumatology (Oxford) 46:342-9. 2007..This study was performed to determine the frequency of erosive arthritis and the pace of radiological progression in an inception cohort of patients with very early RA (<or=3 months after onset of symptoms)...
Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three yearsD Aletaha
Division of Rheumatology, Department of Internal Medicine III, University of Vienna, Austria
Ann Rheum Dis 61:630-4. 2002....
DMARD use in early rheumatoid arthritis. Lessons from observations in patients with established diseaseD Aletaha
Division of Rheumatology, Department of Internal Medicine III, University of Vienna, Vienna General Hospital, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Clin Exp Rheumatol 21:S169-73. 2003..By contrast to changes in DMARD usage, survey data show neither a shortening of referral time nor a change in the approach to diagnose early RA. These data indicate a need for more dissemination of the early arthritis concept...
What should be our treatment goal in rheumatoid arthritis today?J S Smolen
Department of Rheumatology, Medical University of Vienna Second Department of Medicine, Lainz Hospital, Vienna, Austria
Clin Exp Rheumatol 24:S-7-13. 2006....
Duration of rheumatoid arthritis influences the degree of functional improvement in clinical trialsD Aletaha
Intramural Research Program, NIAMS, National Institutes of Health, Bethesda, MD 20892, USA
Ann Rheum Dis 65:227-33. 2006..Functional limitation incorporates both activity and damage. Because irreversible damage increases over time, the HAQ may be less likely to show improvement in late than in early rheumatoid arthritis...
Assessing remission in clinical practiceM Mierau
2nd Department of Medicine, Hietzing Hospital, Vienna, Austria
Rheumatology (Oxford) 46:975-9. 2007..We aimed at evaluating sustained remission in a large cohort of patients followed prospectively in clinical practice and to evaluate available instruments to define remission for their stringency in defining this state...
Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowingJ S Smolen
Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18 20, A 1090, Vienna, Austria
Ann Rheum Dis 68:1535-40. 2009....
[Activity-score based therapy in rheumatoid arthritis]K Machold
Klinische Abt für Rheumatologie, Universitätsklinik für Innere Medizin III, Wien
Z Rheumatol 65:124, 126-30. 2006..This review presents evidence for the benefits of the application disease activity scores in clinical routine...
The use of databases for quality assessment in rheumatoid arthritisT A Stamm
Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
Clin Exp Rheumatol 25:82-5. 2007....
The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD coursesD Aletaha
Division of Rheumatology, Department of Internal Medicine III, University of Vienna, Vienna, Austria
Rheumatology (Oxford) 41:1367-74. 2002..First DMARDs in new patients were retained longer than subsequent DMARDs, apparently because they are more effective...
Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritisD Aletaha
Division of Rheumatology, Department of Internal Medicine III, University of Vienna, Austria
Ann Rheum Dis 62:482-6. 2003..The progression of rheumatoid arthritis (RA) can be retarded or halted by disease modifying antirheumatic drugs (DMARDs). Next to inefficacy, toxicity limits their use...
The burden of rheumatoid arthritis and access to treatment: a medical overviewJ Smolen
Division of Rheumatology, Internal Medicine III, Medical University of Vienna, Vienna, Austria
Eur J Health Econ 8:S39-47. 2008..Therapeutic outcome can be predicted by clinical means...
Glucocorticoid treatment in rheumatoid arthritis: low-dose therapy does not reduce responsiveness to higher dosesJ Wolf
Second Department of Medicine, Hietzing Hospital, Vienna, Austria
Clin Exp Rheumatol 26:113-6. 2008..Since low dose GC has been suggested to confer resistance to higher doses, we aimed to assess if resistance was detectable on the clinical level in patients with active RA...
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: methodological report phase IJulia Funovits
Division of Rheumatology, Medical University Vienna, Waehringer Guertel 18 20, Vienna, Austria
Ann Rheum Dis 69:1589-95. 2010....
Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritisMonika Schoels
Second Department of Medicine, Hietzing Hospital, Vienna, Austria
Ann Rheum Dis 69:1441-7. 2010..Therefore, the reliability and validity of DAREA (for 'Disease Activity index for REactive Arthritis'), which was originally developed for reactive arthritis and employs a 66/68 joint count, was tested in patients with PsA...
Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patientsDaniel Aletaha
Medical University of Vienna, Vienna, Austria
Arthritis Rheum 56:3226-35. 2007..To assess whether disease activity levels at treatment initiation or during the first 3 months of therapy predict disease activity at 1 year after treatment initiation...
Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trialsJosef S Smolen
Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna General Hospital, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Ann Rheum Dis 69:1058-64. 2010..Joint damage is an important outcome in trials of rheumatoid arthritis (RA), usually assessed by Total Sharp Score (TSS). It is currently unknown how it translates numerically into disability by the Health Assessment Questionnaire (HAQ)...
Does damage cause inflammation? Revisiting the link between joint damage and inflammationJ S Smolen
Division of Rheumatology, Department of Internal Medicine 3, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Ann Rheum Dis 68:159-62. 2009..However, the clinical evidence for this relationship is still to be provided as proof of the concept...
[Clinical outcome measures in hand- and finger joint osteoarthritis from the patient perspective]T Stamm
Abt für Rheumatologie, Klinik fur Innere Medizin III, Medizinische Universität Wien
Z Rheumatol 65:139-43. 2006..Some instruments lack reliability because standardized protocols for measurement have not yet been developed...
Challenges of predicting treatment response in patients with rheumatoid arthritisJosef S Smolen
Division of Rheumatology, Medical University of Vienna, Vienna, Austria
Nat Clin Pract Rheumatol 1:62-3. 2005
Evaluation of the appropriateness of composite disease activity measures for assessment of psoriatic arthritisValerie P Nell-Duxneuner
Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Ann Rheum Dis 69:546-9. 2010..Specific composite indices assessing disease activity in psoriatic arthritis (PsA) have not yet been sufficiently validated. The objective of this study was to identify instruments best reflecting disease activity in PsA...
Threats to validity of observational studies on disease-modifying antirheumatic drug therapies for rheumatoid arthritis: new aspects after the fall of the pyramid and the rise of new therapeuticsDaniel Aletaha
Division of Rheumatology, Department of Internal Medicine III, University of Vienna, Vienna General Hospital, Waehringer Guertel 18-20, A-1090 Vienna, Austria
Curr Rheumatol Rep 5:409-12. 2003
Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patientsMarcus D Köller
Department of Rheumatology Internal Medicine III, General Hospital Medical University of Vienna, Vienna, Austria
Rheumatology (Oxford) 48:1575-80. 2009..To compare the efficacy of MTX and MTX+TNF inhibitors (TNFis) in elderly patients with RA with that in patients of younger age...
Impact of comorbidity on physical function in patients with rheumatoid arthritisHelga Radner
Division of Rheumatology, Department of Internal Medicine 3, Medical University Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
Ann Rheum Dis 69:536-41. 2010..Physical disability is a main outcome in rheumatoid arthritis (RA) which tends to increase with comorbidities. However, the extent to which comorbidities contribute to the multifactorial process of disability has not been investigated...
The assessment of disease activity in rheumatoid arthritisJosef S Smolen
Division of Rheumatology, Medical University of Vienna, and Hietzing Hospital, Vienna, Austria
Clin Exp Rheumatol 28:S18-27. 2010..The latest developments in the field are discussed and will help to identify patients who can benefit most from today's opportunities of pharmacotherapy, allowing optimization of patient care...
Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritisHelga Radner
Department of Internal Medicine 3, Medical University Vienna, 1090 Vienna, Austria
Rheumatology (Oxford) 50:381-8. 2011..In this study, we investigated the impact of comorbidities on individual activities of daily living, and other aspects of quality of live in patients with RA...
Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritisJohannes Grisar
Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Circulation 111:204-11. 2005..Because the quantity of endothelial progenitor cells (EPCs) in the peripheral blood is correlated inversely with cardiovascular risk, we studied whether such abnormalities could also be observed in patients with RA...
The public neglect of rheumatic diseases: insights from analyses of attendees in a musculoskeletal disease awareness activityKlaus P Machold
Department of Rheumatology, Internal Medicine III, Medical University of Vienna, Vienna, Austria
Ann Rheum Dis 66:697-9. 2007..To obtain data on the care received by individuals counselled during a public health awareness campaign on painful musculoskeletal conditions (MSC)...
Power Doppler sonography and pulse-inversion harmonic imaging in evaluation of rheumatoid arthritis synovitisClaudia Schueller-Weidekamm
Department of Diagnostic Radiology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
AJR Am J Roentgenol 188:504-8. 2007....
Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapyJohannes Grisar
Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Ann Rheum Dis 66:1284-8. 2007....
Strengths and limitations of a systematic review on DMARDs for rheumatoid arthritisJosef S Smolen
Division of Rheumatology, Medical University of Vienna, Vienna, Austria
Nat Clin Pract Rheumatol 4:296-7. 2008
Concepts important to patients with psoriatic arthritis are not adequately covered by standard measures of functioningTanja A Stamm
Department of Internal Medicine III, Division of Rheumatology, Vienna Medical University, Vienna, Austria
Arthritis Rheum 57:487-94. 2007..To explore whether the concepts important to patients with psoriatic arthritis (PsA) are covered by self-report instruments assessing functioning...
Mapping hand functioning in hand osteoarthritis: comparing self-report instruments with a comprehensive hand function testTanja Stamm
Vienna Medical University, Vienna, Austria
Arthritis Rheum 57:1230-7. 2007..To determine which self-report instruments best explain hand functioning measured by a generic comprehensive hand function test...
The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?Josef S Smolen
Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Arthritis Res Ther 10:208. 2008..The analysis suggests the search for better markers to predict outcomes and therapeutic responsiveness in rheumatoid arthritis needs to be intensified...
Advances in anti-inflammatory therapyD Aletaha
Division of Rheumatology, Department of Internal Medicine III, University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna
Acta Med Austriaca 29:1-6. 2002..NSAIDs have the potential to cause adverse events in the GI tract. Therapy with histamine antagonists or sucralfate did not reduce the patients' rate of gastrointestinal adverse events...
Therapeutic strategies in early rheumatoid arthritisJosef S Smolen
Division of Rheumatology, Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Best Pract Res Clin Rheumatol 19:163-77. 2005..Whether a 'window of opportunity' exists during which effective therapy might lead to cure is still an open issue and will be the focus of clinical trials in the near future...
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsJosef S Smolen
Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Ann Rheum Dis 69:964-75. 2010....
Treating rheumatoid arthritis to target: recommendations of an international task forceJosef S Smolen
Department of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Waehringer Guertel 18 20, Vienna, Austria
Ann Rheum Dis 69:631-7. 2010..Aiming at therapeutic targets has reduced the risk of organ failure in many diseases such as diabetes or hypertension. Such targets have not been defined for rheumatoid arthritis (RA)...
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeDaniel Aletaha
Medical University of Vienna, Vienna, Austria
Arthritis Rheum 62:2569-81. 2010..This work was undertaken to develop new classification criteria for RA...
Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008Monika Schoels
2nd Department of Medicine, Centre for Rheumatic Diseases, Hietzing Hospital, Vienna, Austria
Ann Rheum Dis 69:575-8. 2010..The importance of tight control and early treatment, rapidly altered if goals are not achieved, is supported by evidence. However, it is unknown to what extent these insights are accepted by practitioners in clinical practice...
Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)Michael Bonelli
Division of Rheumatology, Internal Medicine III, General Hospital of Vienna, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Wien, Austria
Int Immunol 20:861-8. 2008..Our data describe quantitative and qualitative defects of Treg in SLE patients. These deficiencies might contribute to the breakdown of self-tolerance and the development of the autoimmune response in SLE patients...
The challenge of following process, damage, and function in patients with rheumatoid arthritis in clinical careJosef S Smolen
Department of Rheumatology, Internal Medicine III, Vienna General Hospital, University of Vienna, Wolkersbergenstrasse 1, Vienna A-1130, Austria
Curr Rheumatol Rep 5:336-40. 2003
Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failureTheresa Kapral
Department of Rheumatology, Internal Medicine III, Medical University of Vienna, Vienna, Austria
Arthritis Res Ther 8:R46. 2006..Re-employment of MTX despite prior inefficacy, but not re-employment of other DMARDs, is an effective therapeutic option, especially in those patients in whom the methotrexate dose of the original course was low...
Early rheumatoid arthritisKlaus P Machold
Department of Rheumatology, Internal Medicine III, Vienna Medical University, Austria
Curr Opin Rheumatol 18:282-8. 2006..Nevertheless, much remains to be studied to better address the issue of early rheumatoid arthritis...
Activity assessments in rheumatoid arthritisJosef S Smolen
Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Austria
Curr Opin Rheumatol 20:306-13. 2008..the importance of assessing disease activity in general, aiming for significant improvement particularly low disease activity and remission, and the value of employing simplified instruments toward this end in rheumatoid arthritis..
Pro-inflammatory cytokines in rheumatoid arthritis: pathogenetic and therapeutic aspectsJosef S Smolen
Division of Rheumatology, Internal Medicine III, Medical University of Vienna, Austria
Clin Rev Allergy Immunol 28:239-48. 2005....
The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical careDaniel Aletaha
Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Best Pract Res Clin Rheumatol 21:663-75. 2007....
The need for new classification criteria for rheumatoid arthritisDaniel Aletaha
Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna General Hospital, Waehringer Guertel 18-20, A-1090 Vienna, Austria
Arthritis Rheum 52:3333-6. 2005
New therapies for treatment of rheumatoid arthritisJosef S Smolen
Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
Lancet 370:1861-74. 2007..Novel therapeutic strategies in conjunction with optimised disease assessment for better treatment of rheumatoid arthritis and an outlook into potential future targets are also presented...
Superior efficacy of combination therapy for rheumatoid arthritis: fact or fiction?Josef S Smolen
Medical University of Vienna and Lainz Hospital, Vienna, Austria
Arthritis Rheum 52:2975-83. 2005
Cytogenetic risk groups in acute myeloblastic leukaemia differ greatly in their semi-solid colony growthL Ohler
Department of Internal Medicine I, University of Vienna, Vienna, Austria
Br J Haematol 113:120-5. 2001..0004). Our data suggest that the growth potential of the leukaemic clone seems to be critically influenced by the molecular changes emerging from chromosomal abnormalities...
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity scoreDaniel Aletaha
Department of Rheumatology, Medical University of Vienna, Vienna, Austria
Arthritis Res Ther 7:R796-806. 2005..e. the sum of tender and swollen joint counts [28 joints] and patient and physician global assessments [in cm]) - would have comparable validity in clinical cohorts...
Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: clinical evaluation and cost analysisDaniel Aletaha
University of Vienna, Vienna, Austria
Arthritis Rheum 47:181-8. 2002..CONCLUSION: Laboratory tests can be reduced substantially in patients receiving DMARD therapy. In consequence, costs can decrease significantly without oversight of adverse events...
Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational studyDaniel Aletaha
Department of Internal Medicine, University of Vienna, Austria
J Rheumatol 29:1631-8. 2002..Their use is more often limited by toxicity than by inefficacy. If tolerated, they can be retained for long periods of time...
Evidence for treating rheumatoid arthritis to target: results of a systematic literature searchMonika Schoels
Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Waehringer Guertel 18 20, Vienna, Austria
Ann Rheum Dis 69:638-43. 2010..To summarise existing evidence on a target oriented approach for rheumatoid arthritis (RA) treatment...
Pooled indices to measure rheumatoid arthritis activity: a good reflection of the physician's mind?Daniel Aletaha
National Institutes of Arthritis, Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
Arthritis Res Ther 8:102. 2006..The choice of index in clinical practice should ideally be based on practical considerations related to the needs of the rheumatologist in the respective health care setting...
Diagnostic and prognostic value of antibodies and soluble biomarkers in undifferentiated peripheral inflammatory arthritis: a systematic reviewMonika Schoels
2nd Department of Internal Medicine, Hietzing Hospital, Vienna, Austria
J Rheumatol Suppl 87:20-5. 2011..We reviewed published evidence on the diagnostic and prognostic performance of autoantibodies and soluble biomarkers in UPIA...
Minimal disease activity for rheumatoid arthritis: a preliminary definitionGeorge A Wells
Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada
J Rheumatol 32:2016-24. 2005..This set of 2 definitions gained approval of 73% of the attendees. These (and other) definitions will now be subject to further validation in other databases...
The American College of Rheumatology N (ACR-N) debate: going back into the middle of the tunnel? Comment on the articles by Siegel and Zhen and by BoersDaniel Aletaha
Arthritis Rheum 54:377-8; author reply 378. 2006
